ckd semaglutide just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Semaglutide significantly reduces risk of

Does pricing increase with higher GLP-1 doses

Indirect Effects: Reduced Food Cravings Leading to Reduced Drinking Opportunities In addition to reduced reward from consuming alcohol while on GLP-1s, slow appetite or reduced appetite may also prevent one from wanting to drink alcohol

About Sodium and Health

Our providers will create a custom weight loss plan tailored to your specific needs and preferences

The most wonderful chart in the book [highlights] that people all over the world universally, are spending more time helping people that they will never meet

The FDA also recommends examining hard clinical endpoints such hepatic decompensations, transplant free survival, and all-cause mortality, although these results are not necessarily needed prior to drug approval given the long length of follow up potentially required